![David Holtz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Holtz
Investitore di Private Equity presso
Provco Ventures
Patrimonio netto: 3 $ in data 30/04/2026
Profilo
David B. Holtz is Vice President at Provco Ventures since 2012.
Formerly, Mr. Holtz was Independent Non-Executive Director at Dynatronics Corp.
from 2015 to 2026, Interim President, CEO, CFO & Vice President at NUCRYST Pharmaceuticals Corp.
from 2008 to 2010, Executive Manager at Grey Street Holdings LLC from 2011 to 2012, Treasurer, Chief Accounting Officer & VP-Finance at Integra LifeSciences Holdings Corp.
from 1993 to 2006, and Associate at Coopers & Lybrand LLP.
Mr. Holtz completed undergraduate studies at Susquehanna University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/10/2025 | 32.968 ( 0,21% ) | 3 $ | 30/04/2026 |
Posizioni attive di David Holtz
| Società | Posizione | Inizio |
|---|---|---|
Provco Ventures
 Provco Ventures Investment ManagersFinance Provco Ventures invests in companies located in the United States. The firm targets companies operating in the fields of technology, healthcare, biotech, alternative energy sectors. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/01/2012 |
Precedenti posizioni note di David Holtz
| Società | Posizione | Fine |
|---|---|---|
| DYNATRONICS CORPORATION | Direttore/Membro del Consiglio | 09/01/2026 |
Grey Street Holdings LLC | Corporate Officer/Principal | 01/01/2012 |
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes medical products that fight infection and inflammation | Direttore Finanziario/CFO | 09/02/2010 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Comptroller/Controller/Auditor | 31/12/2006 |
Coopers & Lybrand LLP
 Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Formazione di David Holtz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
53
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Dynatronics Corp.
 Dynatronics Corp. Medical SpecialtiesHealth Technology Engages in the design, manufacture, marketing and distribution of physical medicine products and aesthetic products | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes medical products that fight infection and inflammation | Health Technology |
Coopers & Lybrand LLP
Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Susquehanna University
 Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures invests in companies located in the United States. The firm targets companies operating in the fields of technology, healthcare, biotech, alternative energy sectors. It provides financing for early stage capital requirements. | Finance |
Grey Street Holdings LLC |
